Fingerprint
Dive into the research topics of 'Selective use of daunorubicin (DNR) in chemotherapy of acute non-lymphoblastic leukemia (ANLL)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Selective use of daunorubicin (DNR) in chemotherapy of acute non-lymphoblastic leukemia (ANLL)
B. S. Shaikh, J. B. Dougherty, Robert Hamilton
Research output: Contribution to journal › Article › peer-review